NIDA is offering the Avant-Garde Award Program for HIV/AIDS and Drug Use Research to support innovative research by exceptional scientists seeking to open new areas and approaches in HIV/AIDS research. This grant aims to fund research with the potential to revolutionize prevention and treatment methods for HIV/AIDS among drug abusers. The program encourages highly creative and transformative research proposals, emphasizing unique and novel ideas different from current research efforts. Eligible projects include basic research for improved interventions, innovative disease prevention strategies, and creative approaches to enhancing the lives of those affected by HIV/AIDS. Closing date for applications is Jul 29, 2016.
Opportunity ID: 251321
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-15-004 |
| Funding Opportunity Title: | NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 13, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 29, 2016 |
| Current Closing Date for Applications: | Jul 29, 2016 |
| Archive Date: | Aug 29, 2016 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments Public and State controlled institutions of higher education County governments Small businesses Private institutions of higher education City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others. The NIDA Avant-Garde award supports innovative, basic research that may lead to improved preventive interventions or therapies; creative, new strategies to prevent disease transmission; novel approaches to improve disease outcomes; and creative approaches to eradicating HIV or improving the lives of those living with HIV. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.279 | FORMS-C | Forms-C | PKG00192775 | Jun 29, 2014 | May 17, 2016 | View |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223546 | Jun 29, 2016 | Jul 29, 2016 | View |
Package 1
Mandatory forms
251321 RR_SF424_2_0-2.0.pdf
251321 PHS398_ResearchPlan_2_0-2.0.pdf
251321 PHS398_CoverPageSupplement_2_0-2.0.pdf
251321 RR_KeyPersonExpanded_2_0-2.0.pdf
251321 RR_OtherProjectInfo_1_3-1.3.pdf
251321 PerformanceSite_2_0-2.0.pdf
Optional forms
251321 PHS398_CumulativeInclusionReport-1.0.pdf
251321 PlannedReport-1.0.pdf
Package 2
Mandatory forms
251321 RR_SF424_2_0-2.0.pdf
251321 PHS398_CoverPageSupplement_3_0-3.0.pdf
251321 RR_OtherProjectInfo_1_3-1.3.pdf
251321 PerformanceSite_2_0-2.0.pdf
251321 RR_KeyPersonExpanded_2_0-2.0.pdf
251321 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
251321 PHS_Inclusion_Enrollment_Report-1.0.pdf
251321 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
